Orlistat
Orlistat is a pharmaceutical drug with 33 clinical trials. Currently 2 active trials ongoing. Historical success rate of 84.6%.
Success Metrics
Based on 22 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
9
Mid Stage
15
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.5%
22 of 27 finished
18.5%
5 ended early
2
trials recruiting
33
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
Clinical Trials (33)
Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
Weight Loss Aid in an Exposed Population
Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility
Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients
Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea
Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults
The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects
A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss
A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 33